Genome wide association studies (GWAS) investigating AD have in the past not been powerful enough to reveal anything except APOE. Two recent large GWAS [22,23], however, collectively investigated over 30,000 individuals (with almost 12,000 probable AD cases) and examined around 500,000 SNPs that may influence AD risk. Here, APOE is linked to Alzheimer disease.